Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.25%37.42B | 4.11%35.89B | 3.04%11.13B | 10.58%9.2B | 0.73%8.82B | 2.19%6.73B | 0.67%34.47B | -2.80%10.81B | 5.86%8.32B | 4.03%8.76B |
| Cost of revenue | 4.66%33.72B | 4.04%32.22B | 3.36%9.92B | 9.45%8.22B | 0.97%8B | 2.38%6.08B | 0.92%30.97B | -2.65%9.6B | 5.90%7.51B | 5.62%7.93B |
| Gross profit | 0.72%3.69B | 4.78%3.67B | 0.50%1.21B | 21.11%981.98M | -1.53%821.56M | 0.45%649.57M | -1.53%3.5B | -4.04%1.21B | 5.50%810.82M | -9.01%834.29M |
| Operating expense | -8.64%2.21B | 2.60%2.42B | 6.60%630.88M | 1.41%589.44M | 0.99%600.45M | 1.39%598.92M | 2.74%2.36B | 5.93%591.81M | 4.20%581.23M | 5.36%594.56M |
| Staff costs | -13.62%1.49B | 0.29%1.72B | ---- | ---- | ---- | ---- | 2.15%1.72B | ---- | ---- | ---- |
| Selling and administrative expenses | -2.95%253.06M | 6.37%260.75M | ---- | ---- | ---- | ---- | 21.54%245.14M | ---- | ---- | ---- |
| -Selling and marketing expense | 61.04%27.32M | 13.18%16.96M | ---- | ---- | ---- | ---- | 2.82%14.99M | ---- | ---- | ---- |
| -General and administrative expense | -7.40%225.75M | 5.92%243.79M | ---- | ---- | ---- | ---- | 23.00%230.16M | ---- | ---- | ---- |
| Depreciation and amortization | 23.61%65.17M | -5.99%52.72M | ---- | ---- | ---- | ---- | -8.39%56.09M | ---- | ---- | ---- |
| -Depreciation | 23.61%65.17M | -5.99%52.72M | ---- | ---- | ---- | ---- | -8.39%56.09M | ---- | ---- | ---- |
| Rent and land expenses | 3.14%42.26M | 17.38%40.98M | ---- | ---- | ---- | ---- | -6.84%34.91M | ---- | ---- | ---- |
| Other operating expenses | 5.82%360.33M | 12.59%340.52M | ---- | ---- | ---- | ---- | -2.89%302.43M | ---- | ---- | ---- |
| Operating profit | 18.87%1.48B | 9.28%1.25B | -5.37%583.5M | 70.97%392.54M | -7.77%221.11M | -9.46%50.65M | -9.32%1.14B | -12.00%616.58M | 8.91%229.6M | -32.00%239.73M |
| Net non-operating interest income (expenses) | 79.80%13.42M | 22.97%7.46M | 14.08%2.05M | 43.64%2.33M | -11.27%1.34M | 52.84%1.75M | 65.07%6.07M | 49.25%1.8M | 75.90%1.62M | 77.00%1.51M |
| Non-operating interest income | 79.80%13.42M | 18.18%7.46M | 14.08%2.05M | 42.50%2.33M | -15.21%1.34M | 33.77%1.75M | 15.09%6.31M | 21.34%1.8M | 23.90%1.63M | 15.52%1.58M |
| Non-operating interest expense | ---- | --0 | --0 | ---- | ---- | --0 | -86.41%246K | --0 | -96.73%13K | -86.38%70K |
| Net investment income | 20.06%109.55M | 56.84%91.25M | 52.71%2.54M | 24.04%25.25M | -32.56%3.09M | 91.14%60.37M | -21.12%58.18M | 13.29%1.66M | 21.99%20.35M | -84.67%4.58M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 63.33M | 0 | 28.56M | 0 | 34.77M | 0 | 0 | 0 | 0 |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -89.07%2.81M | 184.26%25.69M | 673.66%23.88M | -1,312.72%-21.45M | 448.79%18.85M | -53.93%4.42M | 2,393.91%9.04M | 135.80%3.09M | -38.41%1.77M | -110.15%-5.4M |
| Less:Other special charges | 89.07%-2.81M | -204.00%-25.69M | -169.02%-27.67M | --22.38M | -964.41%-22.32M | 356.49%1.92M | -2,244.92%-8.45M | -22,460.87%-10.29M | --0 | 2,145.22%2.58M |
| Less:Write off | ---- | --0 | -47.38%3.79M | 47.43%-930K | 23.15%3.47M | 28.35%-6.33M | ---587K | -16.07%7.2M | 38.41%-1.77M | 14.86%2.82M |
| Other non-operating income (expenses) | -27.16%63.33M | -25.01%86.94M | -60.11%21.91M | 7.15%38.74M | 13.22%16.24M | -4.23%10.05M | 74.35%115.93M | -5.55%54.94M | 299.14%36.15M | 219.68%14.35M |
| Income before tax | 9.85%1.67B | 14.38%1.52B | -6.52%633.87M | 60.96%465.96M | 2.30%260.62M | 48.97%162M | -9.85%1.33B | -9.79%678.06M | 20.45%289.49M | -42.57%254.76M |
| Income tax | 17.11%538.67M | 15.73%459.98M | 2.51%171.55M | 117.23%163.47M | -19.77%92.42M | -17.95%32.53M | -0.02%397.45M | -26.33%167.36M | -41.67%75.26M | -13.07%115.19M |
| Net income | 6.70%1.13B | 13.80%1.06B | -9.47%462.32M | 41.20%302.48M | 20.51%168.2M | 87.37%129.47M | -13.47%933.61M | -2.63%510.71M | 92.44%214.23M | -55.14%139.57M |
| Net income continuous operations | 6.70%1.13B | 13.80%1.06B | -9.47%462.32M | 41.19%302.48M | 20.51%168.2M | 87.37%129.47M | -13.47%933.61M | -2.63%510.71M | 92.44%214.23M | -55.14%139.57M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 6.70%1.13B | 13.80%1.06B | -9.47%462.32M | 41.20%302.48M | 20.51%168.2M | 87.37%129.47M | -13.47%933.61M | -2.63%510.71M | 92.44%214.23M | -55.14%139.57M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 6.70%1.13B | 13.80%1.06B | -9.47%462.32M | 41.20%302.48M | 20.51%168.2M | 87.37%129.47M | -13.47%933.61M | -2.63%510.71M | 92.44%214.23M | -55.14%139.57M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 9.03%103.96 | 17.28%95.35 | -6.91%41.49 | 45.97%27.15 | 24.40%15.09 | 93.67%11.62 | -13.25%81.3 | -2.17%44.57 | 92.35%18.6 | -55.11%12.13 |
| Diluted earnings per share | 9.03%103.96 | 17.28%95.35 | -6.91%41.4881 | 45.94%27.1447 | 24.47%15.09 | 93.67%11.62 | -13.25%81.3 | -2.17%44.57 | 92.36%18.6 | -55.13%12.1233 |
| Dividend per share | 20.00%42 | 16.67%35 | 16.67%35 | 0 | 0 | 0 | 7.14%30 | 7.14%30 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |